Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 14, 2025 • 5:00 AM ET

Date/Time Source News Release
05/08/2025 08:00 AM EDT GlobeNewswire VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update
04/25/2025 08:00 AM EDT GlobeNewswire VYNE Therapeutics Provides Update on VYN202 Program
03/20/2025 08:00 AM EDT GlobeNewswire VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
03/06/2025 08:00 AM EST GlobeNewswire VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update
02/20/2025 08:00 AM EST GlobeNewswire VYNE Therapeutics to Participate in March Investor Conferences
02/19/2025 08:00 AM EST GlobeNewswire VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis
01/06/2025 07:30 AM EST GlobeNewswire VYNE Therapeutics Completes Enrollment in Phase 2b Trial Evaluating VYN201 for the Treatment of Nonsegmental Vitiligo
12/23/2024 07:30 AM EST GlobeNewswire VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor
11/07/2024 08:00 AM EST GlobeNewswire VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
09/12/2024 08:00 AM EDT GlobeNewswire VYNE Therapeutics Announces Positive Phase 1a SAD Data for VYN202, a Novel BD2-Selective BET Inhibitor
Page

Additional News

As of May 14, 2025 • 5:00 AM ET

Date/Time Source News Release
05/08/2025 08:40 AM EDT SeekingAlpha VYNE Therapeutics GAAP EPS of -$0.20, revenue of $0.2M
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - VYNE Therapeutics Inc.
03/06/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, March 6th, 2025
03/06/2025 04:31 AM EST US Earnings Reports Expected earnings - VYNE Therapeutics Inc.
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - VYNE Therapeutics Inc.
11/07/2024 09:15 AM EST SeekingAlpha VYNE Therapeutics GAAP EPS of -$0.29, revenue of $0.1M
11/07/2024 09:15 AM EST Zacks VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates
11/04/2024 08:10 AM EST Zacks BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates
08/15/2024 03:25 AM EDT SeekingAlpha VYNE Therapeutics GAAP EPS of -$0.22 beats by $0.01, revenue of $0.2M beats by $0.09M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.